Blair Madison, Ph.D.
Chief Scientific Officer, Gene Therapy
![blair-madison](https://poseida.com/wp-content/uploads/2024/03/blair-madison.jpg)
Dr. Madison is our Chief Scientific Officer, Gene Therapy, after joining Poseida in 2019 and most recently serving as Vice President, Genetic Engineering. At Poseida, he has played a leading role in advancing allogeneic CAR-T programs and developing key platforms, including the Cas-CLOVER nuclease and site-specific super piggyBac for applications in cell and gene therapies. Prior to Poseida, Dr. Madison was a tenure-track Assistant Professor of Medicine and a National Institutes of Health (NIH)-funded investigator at Washington University in St. Louis, Missouri, and before that was a Postdoctoral Fellow in genetics at the University of Pennsylvania. Earlier in his career, he led R&D efforts at Transposagen Biopharmaceuticals as the Vice President of Research. Dr. Madison holds a B.A. in Biology from Washington University and a Ph.D. in Cell and Molecular Biology from the University of Michigan.